2022 Annual Meeting

Session: Advances in Drug Discovery Processes (including HTE): Advanced Technology Approaches to Maximize Public Health Impacts

Chair

Co-Chair

Presentations

03:30 PM

(565a) CDER Efforts on Pharmaceutical Manufacturing Modernization
Stelios Tsinontides

03:51 PM

(565b) Molecular Discovery with Limited Human Input Using a Machine Learning Guided Automated Platform
Matthew McDonald, Brent Koscher, Richard Canty, Seung Kyun Ha, Camille Bilodeau, Klavs Jensen

04:12 PM

(565c) Computational Discovery of Peptide Inhibitors That Neutralize C. Diff. Toxin a in Jejunum and Colon Epithelial Cells
Sudeep Sarma, Xingqing Xiao, Stefano Menegatti, Nathan Crook, Scott Magness, Carol Hall

04:33 PM

(565d) Identification of Resistance Determinants in Laboratory Evolved Mycobacterium Smegmatis evolved Under Temporally Variable Drug Profiles
Sarika Mehra, Akanksha Kashyap

04:54 PM

(565e) Prediction of the Formation of Co-Amorphous Systems By Means of a Machine Learning Approach
Elisabeth Fink, Michael Brunsteiner, Amrit Paudel, Sarah Zellnitz-Neugebauer

05:15 PM

(565f) Engineered Anti-CD276 Mab to Deliver Payload for Cancer Treatment
Yingnan Si, Xiaoguang Liu

05:36 PM

(565g) A New Strategy for Persister Control
Sweta Roy, Zeynep Cakmak, Dacheng Ren